 Bismuth subsalicylate treatment acute diarrhea children clinical study Bismuth subsalicylate BSS double-blind placebo-controlled study adjunct rehydration therapy children months acute diarrhea regimen mg/kg times days Significant benefits BSS group placebo decreases stool frequency stool weights improvement stool consistency significant improvement clinical well-being shortening disease duration Patients BSS significant reduction duration hospital stay days placebo-treated patients days intravenous fluid requirements degree BSS-treated group Bismuth subsalicylate clearance pathogenic Escherichia coli stools cases different placebo rotavirus elimination Bismuth subsalicylate reported adverse effects Blood bismuth serum salicylate levels levels toxic study BSS effective adjunctive therapy acute diarrhea children demand nursing hospital staff